Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02661828 · ClinicalTrials.gov registry record · NA

Tapering Off Antidepressants

A NA study, sponsored by Emory University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT02661828: Clinical Trial NA study, sponsored by Emory University.

NCT02661828 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02661828, a NA study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The purpose of this study is to compare two ways to stop taking an antidepressant medication and determine whether a faster or slower taper is better tolerated.

Primary Outcome

To determine a change in the frequency of Discontinuation symptoms, the Discontinuation Emergent Signs and Symptoms Scale (DESS) will be administered by a trained clinician/rater to assess the frequency of discontinuation symptoms. The assessment has 43 items to evaluate discontinuation-emergent symptoms resulting from withdrawal from their antidepressant medication. Symptoms are rated on a scale of 1-5: 1. New symptom 2. Old symptom but worse 3. Old symptom but improved 4. Old symptom but unch

Interventions

  • OTHER Two-Week Antidepressant Taper Regimen
  • OTHER One-Week Antidepressant Taper Regimen

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2016-01
Est. Completion 2017-03-17
Phase NA
Emory University

1,208 total trials

Why NCT02661828 stopped before completion

NCT02661828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Two-Week Antidepressant Taper Regimen is the first listed.

NCT02661828 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02661828 about?

NCT02661828 is a clinical study titled "Tapering Off Antidepressants". The purpose of this study is to compare two ways to stop taking an antidepressant medication and determine whether a faster or slower taper is better tolerated.

What is the current status of trial NCT02661828?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-01. Estimated completion is 2017-03-17.

What interventions are being tested in trial NCT02661828?

The interventions under investigation include: Two-Week Antidepressant Taper Regimen (OTHER), One-Week Antidepressant Taper Regimen (OTHER).

Who is sponsoring clinical trial NCT02661828?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02661828's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02661828, the US trial registry maintained by the National Library of Medicine. NCT02661828 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.